JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

First published online November 7, 2008, 10.2967/jnumed.108.054379
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnumed.108.054379v1
49/12/1922    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hokari, M.
Right arrow Articles by Iwasaki, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hokari, M.
Right arrow Articles by Iwasaki, Y.
Journal of Nuclear Medicine Vol. 49 No. 12 1922-1927
© 2008 by Society of Nuclear Medicine
doi: 10.2967/jnumed.108.054379

Clinical Investigation

Combination of a Mean Transit Time Measurement with an Acetazolamide Test Increases Predictive Power to Identify Elevated Oxygen Extraction Fraction in Occlusive Carotid Artery Diseases

Masaaki Hokari1, Satoshi Kuroda1, Tohru Shiga2, Naoki Nakayama1, Nagara Tamaki2 and Yoshinobu Iwasaki1

1 Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan; and 2 Department of Nuclear Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan

Correspondence: For correspondence or reprints contact: Masaaki Hokari, Department of Neurosurgery, Hokkaido University Graduate School of Medicine, North 15 West 7, Kita-ku, Sapporo 060-8638, Japan. E-mail: karimasa{at}med.hokudai.ac.jp

Reduced cerebral blood flow and cerebrovascular reactivity to acetazolamide have been used as predictors for subsequent ischemic stroke in patients with occlusive carotid artery diseases, called type 3 ischemia. However, recent studies have shown that reduced cerebrovascular reactivity to acetazolamide does not always represent elevated oxygen extraction fraction (OEF). The aim of this study was to establish the methodology to improve the validity of an acetazolamide test identifying elevated OEF. Methods: This study included 65 patients who developed transient ischemic attack or minor completed stroke attributable to occlusive carotid artery diseases. Hemodynamic and metabolic parameters in the bilateral middle cerebral artery territories were determined in all patients by 15O-gas PET. Results: Type 3 ischemia alone had 100% sensitivity and 83.2% specificity for identifying elevated OEF, but its positive predictive value and accuracy were low, 47.2% and 0.85, respectively. However, type 3 ischemia and delayed mean transit time combined had an 83.3% positive predictive value and 0.96 accuracy. Conclusion: The results strongly suggest that type 3 ischemia and delayed mean transit time together may be powerful predictors in identifying elevated OEF with high sensitivity and specificity, predictive values, and accuracy. SPECT may be able to define the patients with elevated OEF more easily and at lower costs than PET, although further study would be necessary to compare the results by using SPECT.

Key Words: cerebral ischemia • acetazolamide • oxygen extraction fraction • mean transit time • carotid artery

COPYRIGHT © 2008 by the Society of Nuclear Medicine, Inc.


Related articles in JNM:

This Month in JNM

JNM 2008 49: 11A-12A. [Full Text]  





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2008 by the Society of Nuclear Medicine.